Nova Mentis Life Science Corp. (NMLSF)
NMLSF Stock Price Chart
Explore Nova Mentis Life Science Corp. interactive price chart. Choose custom timeframes to analyze NMLSF price movements and trends.
NMLSF Company Profile
Discover essential business fundamentals and corporate details for Nova Mentis Life Science Corp. (NMLSF) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
27 Jun 2008
Employees
—
Website
https://www.novamentis.caCEO
Steve Loutskou
Description
Nova Mentis Life Science Corp., through its subsidiaries, engages in developing diagnostics and psilocybin based therapeutics for neuroinflammatory conditions with a focus on autism spectrum disorder and fragile X syndrome in Canada. It is also involved in the research and development of anti-inflammatory effects of psilocybin for metabolic indications, such as obesity and diabetes; and development of cannabis products. Nova Mentis Life Science Corp. has a research agreement with the University of Central Florida (UCF) to develop a saliva serotonin assay. The company was formerly known as Liberty Leaf Holdings Ltd. and changed its name to Nova Mentis Life Science Corp. in June 2020. Nova Mentis Life Science Corp. was incorporated in 2004 and is headquartered in Vancouver, Canada.
NMLSF Financial Timeline
Browse a chronological timeline of Nova Mentis Life Science Corp. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 20 May 2026
Upcoming earnings on 20 May 2026
Upcoming earnings on 27 Nov 2025
Earnings released on 25 Aug 2025
Earnings released on 22 May 2025
EPS came in at -$21.51 .
Earnings released on 8 Apr 2025
EPS came in at $0.00 .
Stock split effective on 24 Feb 2025
Shares were split 1 : 2 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 27 Nov 2024
EPS came in at $0.02 .
Stock split effective on 8 Nov 2024
Shares were split 1 : 5 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 26 Aug 2024
EPS came in at -$0.00 .
Earnings released on 29 May 2024
EPS came in at -$0.01 .
Earnings released on 26 Apr 2024
EPS came in at -$0.01 , while revenue for the quarter reached -$21.34K .
Earnings released on 28 Dec 2023
EPS came in at -$0.01 , while revenue for the quarter reached $20.93K .
Earnings released on 29 Aug 2023
EPS came in at -$0.02 .
Earnings released on 30 May 2023
EPS came in at -$0.05 .
Earnings released on 31 Mar 2023
EPS came in at -$0.03 .
Earnings released on 30 Sept 2022
EPS came in at -$0.02 .
Earnings released on 30 Jun 2022
EPS came in at -$0.02 .
Earnings released on 31 Mar 2022
EPS came in at -$0.04 .
Earnings released on 31 Dec 2021
EPS came in at -$0.02 .
Earnings released on 30 Sept 2021
EPS came in at -$0.10 .
Earnings released on 30 Jun 2021
EPS came in at -$0.03 .
Earnings released on 31 Mar 2021
EPS came in at -$0.04 .
Earnings released on 31 Dec 2020
EPS came in at -$1.64 , while revenue for the quarter reached $1.20K .
Earnings released on 30 Sept 2020
EPS came in at -$0.07 , while revenue for the quarter reached $989.23 .
NMLSF Stock Performance
Access detailed NMLSF performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.